of vascular surgeries lead to unplanned hospital readmission 42% 15% 5X increase in cost to patients & 119% increase in costs to hospital Healey et al. Arch Surg. 2002 Vonlathen et al. Annals of Surg.
Centers • Medical Schools • Hospitals • Research • Military Market growing at 16% CAGR “Healthcare/Medical Simulation Market.” Markets and Markets, 2018
Knapp COO & Co-Founder Drew Mouton Strategy Director Biomedical engineer with a passion for design and prior experience commercializing biotech at the New Orleans Bioinnovation Center. Previously developed simulations for the Tulane Center for Advanced Medical Simulation. Talented with 3D printers and silicone casting. Currently the Chief Innovation Officer at LSU Health Sciences Center. Serial entrepreneur and former CEO of publicly traded company.
and LSU Fall 2020 Secure manufacturing partnership Fall 2019 Provisional patent filed Summer 2020 Published White Paper Winter 2020 Market launch and begin expansion into other surgical disciplines Field validation of first product
with vascular surgeons • Connections with ASU/Mayo and UA Medical School, local hospitals • Building out Advisory Board • Manufacturing products for validation study • Publishing White Paper • Marketing • New product development • Staffing
this before. This would be great in our surgical training programs. Dr. Christopher DuCoin Former Surgical Clerkship Director at Tulane School of Medicine www.resuture.com [email protected] /company/resuture-llc /resuture @re_suture